Epilepsy can have a huge impact on people living with a brain tumour. In fact, up to 85% of patients with a low grade glioma experience seizures and up to 60% with a high grade.
We know how devastating the condition can be. The loss of independence, living with uncertainty, and the impact that taking medication has on top of a brain tumour diagnosis can be overwhelming.
That’s why we’re delighted to be working in collaboration with Epilepsy Research UK to identify the key research priorities for tumour-associated epilepsy. The collaboration began at a recent international workshop entitled ‘Tumour-associated epilepsy: bridging the translational gap’, which shared the latest research in the field.
We’re now working together with leading researchers and clinicians to address the challenges that a diagnosis brings, so that people living with tumour-associated epilepsy can live the best quality of life possible.